EyeGene Inc. | Income Statement
Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
186,189.70
153,793.70
107,562.10
267,234.90
301,033.80
Cost of Goods Sold (COGS) incl. D&A
377,452.00
-
-
-
625,338.40
Gross Income
191,262.30
-
-
-
324,304.60
SG&A Expense
3,492,219.90
3,092,445.30
5,117,065.00
8,598,552.70
8,863,827.20
EBIT
3,731,074.20
3,071,741.60
5,167,530.80
8,590,835.80
9,292,861.80
Unusual Expense
43,419.00
-
21,185.00
-
-
Non Operating Income/Expense
94,298.10
54,826.80
29,208.20
1,870.10
266.70
Interest Expense
-
-
-
-
42,172.80
Pretax Income
3,819,790.20
2,923,088.40
4,898,693.90
8,268,090.10
8,810,306.40
Income Tax
-
-
1,747.90
1,747.90
359,416.30
Equity in Affiliates
35,068.60
2,746.90
145.10
-
-
Consolidated Net Income
3,854,858.80
2,925,835.30
4,897,091.10
8,269,838.00
8,450,890.00
Net Income
3,854,858.80
2,925,835.30
4,897,091.10
8,269,838.00
8,450,890.00
Net Income After Extraordinaries
3,854,858.80
2,925,835.30
4,897,091.10
8,269,838.00
8,450,890.00
Net Income Available to Common
3,854,858.80
2,925,835.30
4,897,091.10
8,269,838.00
8,450,890.00
EPS (Basic)
385.49
292.58
562.00
825.00
837.00
Basic Shares Outstanding
10,000.00
10,000.00
8,706.30
10,019.90
10,102.50
EPS (Diluted)
385.49
292.58
562.48
825.34
836.51
Diluted Shares Outstanding
10,000.00
10,000.00
8,706.30
10,019.90
10,102.50
EBITDA
3,693,019.20
2,995,208.60
5,059,490.80
8,419,502.80
8,871,195.80
Other Operating Expense
47,592.00
56,557.00
49,988.00
88,185.00
104,730.00
Non-Operating Interest Income
49,001.00
93,826.40
115,678.70
309,662.80
170,758.70
Equity in Affiliates (Pretax)
-
-
-
-
298,732.80
About EyeGene
View Profile
